ARE THERE ALTERNATIVES TO ANTIMICROBIAL THERAPY AND PROPHYLAXIS OF UNCOMPLICATED URINARY TRACT INFECTIONS?


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The acute uncomplicated cystitis in women is one of the most frequently diagnosed bacterial infection. A clinically symptomatic urinary tract infection must be differentiated from the asymptomatic bacteriuria, which is not considered an infection but rather a colonization which should not be treated. For the antimicrobial therapy according to the European guidelines the old oral antibiotics (fosfomycin trometamol, nitrofurantoin, pivmecillinam) should be prescribed, against which E. coli is still susceptible in over 90%. With new therapeutic concepts not mainly the elimination of bacteria but rather the treatment of the inflammatory (over)reaction of the host is highlighted. To establish the significance of these therapeutic options as compared to the standard antibiotic therapy, the results of the ongoing and planned phase 3 studies need to be awaited. Thus reliable clinical measuring parameters for diagnostics and outcome are needed. The acute cystitis symptom score (ACSS) was developed and validated in Russian and Uzbec languages. Because of its high reliability, validity and predictive value it can be used not only in daily practice but also for clinical studies for the diagnosis of an acute uncomplicated cystitis in women.

Full Text

Restricted Access

About the authors

Kurt G. Naber

Technical University of Munich

Email: kurt@nabers.de
doctor, MD, Associate Professor at the Department of Urology Munich, Germany

J. F Alidjanov

Republican Specialized Center of Urology (RSCU)

Tashkent, Uzbekistan

References

  1. Kass E.H. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 1960; 44:194-198.
  2. Wagenlehner F.M.E., Naber K. G. Asymptomatic bacteriuria - shift of paradigm. Clin Infect Dis 2012;55:778-779.
  3. Nicolle L.E., Bradley S., Colgan R., Rice J.C., Schaeffer A., Hooton T.M. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40:643-654.
  4. Nicolle L.E. Asymptomatic bacteriuria - to treat or not to treat. In: Naber K.G., Schaeffer A.J., Heyns C., Matsumoto T., Shoskes D., Bjerklund-Johansen T.E., eds. Urogenital infections. Arnhem, Netherlands: European Association of Urology-International Consultation on Urological Diseases, 2010: 303-313.
  5. Salvador E., Wagenlehner F., Koehler C.D., Mellmann A., Hacker J., Svanborg C., Dobrindt U. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 2012; 80:668-678.
  6. Wullt B., Sundén F. Asymptomatic bacteriuria with the model strain Escherichia coli 83972 protects against symptomatic urinary tract infections. In: Naber K.G., Schaeffer A.J., Heyns C., Matsumoto T., Shoskes D., Bjerklund-Johansen T.E., eds. Urogenital infections. Arnhem, Netherlands: European Association of Urology-International Consultation on Urological Diseases, 2010:314-318. http :// www.icud.info/urogenitalinfections.html
  7. Cai T., Mazzoli S., Mondaini N. et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis 2012; 55:771-777.
  8. Grabe M., Bjerklund Johansen T.E., Botto H., Wullt B., Cek M., Naber K.G., Pickard R.S., Tenke P., Wagenlehner F. Guidelines on urological infections. European Association of Urology, Arnhem, The Netherlands, 2014. Part 19. Р. 1-107. ISBN/EAN: 978-90-79754-65-6. http://www.uroweb.org/gls/pdf/19%20 Urological% 20infections_LR.pdf
  9. Naber K.G., Cho Y.-H., Matsumoto T., Schaeffer A.J. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicr Agents 2009;33:111-119.
  10. Falagas M.E., Kotsantis I.K., Vouloumanou E.K. et al. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 2009;58:91-102.
  11. Warren J. W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-758.
  12. Naber K.G., Schito G., Botto H., Palou J., Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 2008;54:1164-1178.
  13. Lee S.-J., Lee D.S., Choe H.S., Shim B.S., Kim C.S., Kim M.E., Cho Y.-H. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System. J Infect Chemother 2011; 17:440-446.
  14. Kahlmeter G., Odén Poulsen H. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO • SENS study revisited. Int J Antimicr Agents 2012;39:45-51.
  15. Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G., Moran G.J., Nicolle L.E., Raz R., Schaeffer A.J., Soper D.E. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases 2011 ;52(5):e103-e120.
  16. Wagenlehner F.M.E., Schmiemann G., Hoyme U., Fuenfstueck R., Hummers-Pradier E., Kaase M., Kniehl E., Selbach I., Sester U., Vahlensieck W., Watermann D., Naber K.G. Epidmiology, diagnostics, therapy and management of uncomplicated bacterial community acquired urinary tract infections in adults. S-3 Guideline AWMF-Register-Nr. 043/044 Urinary Tract Infections. http://www.awmf.org/fileadmin/user_upload/Leitlinien/043_D_ Ges_fuer_Urologie/043-044ke_S3_Urinary_Tract_ Infections.pdf
  17. Bleidorn J., Gágyor I., Kochen M.M., Wegscheider K., Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (cipro-floxacin) for uncomplicated urinary tract infection? -Results of a randomized controlled pilot trial. BMC Medicine 2010;8:30-37.
  18. ClinicalTrials.gov Identifier: NCT01488955. Immediate vs conditional use of antibiotics in uncomplicated urinary tract infections: ibuprofen vs. fosfomycin-trometamol. http:// clinicaltrials.gov/ct2/show/NCT01488955?term=fosfomycin&ra nk=13
  19. ClinicalTrials.gov Identifier: NCT01039545. Symptomatic therapy of uncomplicated lower urinary tract infections: diclofenac vs norfloxacin. http://clinicaltrials.gov/ct2/show/NCT01039545?te rm=fosfomycin&rank= 15
  20. Brenneis C., Künstle G., Haunschild J. Spasmolytic activity of Canephron® N on the contractility of isolated urinary bladder. Poster. 13th International Congress Ethnopharmacology, Graz, Österreich, 2. bis 6. September 2012.
  21. Künstle G., Brenneis C., Haunschild J. Efficacy of Canephron® N against bacterial adhesion, inflammation and bladder hyperactivity. Poster. 28th Annual Congress of the European Association of Urology (EAU), Mailand, Italien, 15. bis 19. März 2013.
  22. Künstle G., Brenneis C., Pergola C., Werz O., Haunschild J. Anti-inflammatory effects of Canephron® N and effectiveness in a model of interstitial cystitis. Poster. 65. Kongress der Deutschen Gesellschaft für Urologie (DGU), Dresden, 25. bis 28. September 2013a.
  23. ClinicalTrials.gov Identifier: NCT01478620. Safety and efficacy of Canephron®N in the management of uncomplicated urinary tract infections. http://climcaltrials.gov/ct2/results?term=NCT014786 20&Search=Search
  24. Naber K., Steindl H., Abramov-Sommariva D., Eskoetter H. Non-antibiotic herbal therapy of uncomplicated lower urinary tract infections in women - a pilot study (Poster + Abstract). 61st International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research, Muenster, Germany, 1-5 September 2013. Planta Medica 2013;79:1140.
  25. Alidjanov J.F., Abdufattaev U.A., Makhsudov S.A., Pilatz A., Akilov F.A., Naber K.G., Wagenlehner F.M. New self-reporting questionnaire to assess urinary tract infections and differential diagnosis: acute cystitis symptom score. Urologia Internationalis 2014;92:230-236.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies